142 related articles for article (PubMed ID: 35402625)
21. Identification of LOXL3-associating immune infiltration landscape and prognostic value in hepatocellular carcinoma.
Wang N; Zhou X; Tang F; Wang X; Zhu X
Virchows Arch; 2021 Dec; 479(6):1153-1165. PubMed ID: 34448895
[TBL] [Abstract][Full Text] [Related]
22. Identification of ACSF gene family as therapeutic targets and immune-associated biomarkers in hepatocellular carcinoma.
Zhao Z; Liu M; Xu Z; Cai Y; Peng B; Liang Q; Yan Y; Liu W; Kang F; He Q; Hong Q; Zhang W; Li J; Peng J; Zeng S
Aging (Albany NY); 2022 Oct; 14(19):7926-7940. PubMed ID: 36205594
[TBL] [Abstract][Full Text] [Related]
23. Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma.
Chen H; Li Y; Xiao SY; Guo J
BMC Cancer; 2021 Mar; 21(1):278. PubMed ID: 33726698
[TBL] [Abstract][Full Text] [Related]
24. Low expression of moonlight gene ALAD is correlated with poor prognosis in hepatocellular carcinoma.
Ye Q; Yang X; Zheng S; Mao X; Shao Y; Xuan Z; Huang P
Gene; 2022 May; 825():146437. PubMed ID: 35318110
[TBL] [Abstract][Full Text] [Related]
25. Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma.
Mo Z; Liu D; Rong D; Zhang S
Front Immunol; 2021; 12():611058. PubMed ID: 33679749
[No Abstract] [Full Text] [Related]
26. Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer.
Cajuso T; Hänninen UA; Kondelin J; Gylfe AE; Tanskanen T; Katainen R; Pitkänen E; Ristolainen H; Kaasinen E; Taipale M; Taipale J; Böhm J; Renkonen-Sinisalo L; Mecklin JP; Järvinen H; Tuupanen S; Kilpivaara O; Vahteristo P
Int J Cancer; 2014 Aug; 135(3):611-23. PubMed ID: 24382590
[TBL] [Abstract][Full Text] [Related]
27. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
Front Immunol; 2021; 12():719175. PubMed ID: 34603293
[TBL] [Abstract][Full Text] [Related]
28. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
29. Identification of prognostic biomarkers associated with the occurrence of portal vein tumor thrombus in hepatocellular carcinoma.
Lin T; Lin Z; Mai P; Zhang E; Peng L
Aging (Albany NY); 2021 Apr; 13(8):11786-11807. PubMed ID: 33878734
[TBL] [Abstract][Full Text] [Related]
30. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis.
Xiao H; Wang B; Xiong HX; Guan JF; Wang J; Tan T; Lin K; Zou SB; Hu ZG; Wang K
J Cell Physiol; 2021 Apr; 236(4):2572-2591. PubMed ID: 32853412
[TBL] [Abstract][Full Text] [Related]
31. The stage-dependent prognostic role of
Zhou H; Sun D; Miao C; Tao J; Ge C; Chen T; Li H; Hou H
Transl Cancer Res; 2023 Nov; 12(11):3088-3104. PubMed ID: 38130310
[TBL] [Abstract][Full Text] [Related]
32. A Comprehensive Prognostic Analysis of POLD1 in Hepatocellular Carcinoma.
Tang H; You T; Sun Z; Bai C
BMC Cancer; 2022 Feb; 22(1):197. PubMed ID: 35189839
[TBL] [Abstract][Full Text] [Related]
33. A novel DNA methylation-based model that effectively predicts prognosis in hepatocellular carcinoma.
Hao XY; Li AQ; Shi H; Guo TK; Shen YF; Deng Y; Wang LT; Wang T; Cai H
Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33634306
[TBL] [Abstract][Full Text] [Related]
34. The Clinicopathologic Significance of BAF250a (ARID1A) Expression in Hepatocellular Carcinoma.
Zhao J; Chen J; Lin H; Jin R; Liu J; Liu X; Meng N; Cai X
Pathol Oncol Res; 2016 Jul; 22(3):453-9. PubMed ID: 26589513
[TBL] [Abstract][Full Text] [Related]
35. Identification of prognostic alternative splicing events related to the immune microenvironment of hepatocellular carcinoma.
Yu S; Cai L; Liu C; Gu R; Cai L; Zhuo L
Mol Med; 2021 Apr; 27(1):36. PubMed ID: 33832428
[TBL] [Abstract][Full Text] [Related]
36. Identification of immunological subtypes of hepatocellular carcinoma with expression profiling of immune-modulating genes.
Cao D; Chen MK; Zhang QF; Zhou YF; Zhang MY; Mai SJ; Zhang YJ; Chen MS; Li XX; Wang HY
Aging (Albany NY); 2020 Jun; 12(12):12187-12205. PubMed ID: 32544882
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma.
Yu ZL; Zhu ZM
Bioengineered; 2021 Dec; 12(1):1708-1724. PubMed ID: 33955330
[TBL] [Abstract][Full Text] [Related]
38. The relationship among Girdin DNA methylation, its high expression, and immune infiltration in hepatocellular carcinoma: Clues from in silico analysis.
Zhang C; Ke Y; Lei X; Liu X; Li H; Shi R; Wang L
Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33660763
[TBL] [Abstract][Full Text] [Related]
39. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma.
Fang Q; Chen H
Mol Med; 2020 Jun; 26(1):60. PubMed ID: 32552682
[TBL] [Abstract][Full Text] [Related]
40. Identification of a glycolysis-related gene signature for predicting prognosis in patients with hepatocellular carcinoma.
Kong J; Yu G; Si W; Li G; Chai J; Liu Y; Liu J
BMC Cancer; 2022 Feb; 22(1):142. PubMed ID: 35123420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]